ARK Innovation Trims Robinhood After 21% Gain, Adds Circulomics During Slump
HOOD•Cathie Wood's ARK Innovation ETF reduced its Robinhood position after shares surged over 21% in the past year and reallocated funds into Circulomics, whose shares have recently underperformed. This shift marks a strategic rotation from a top-performing fintech holding to a lagging biotech name in ARK's portfolio.
1. Portfolio Rebalancing
ARK Innovation ETF trimmed its Robinhood stake after the stock delivered a 21% year-over-year gain, signaling profit-taking on the fintech broker that has outpaced the broader market.
2. New Circulomics Allocation
Capital freed from Robinhood was used to establish or increase a position in Circulomics, targeting the biotech’s recent share price decline as a buying opportunity.
3. Strategic Implications
The rotation underscores ARK’s active management approach of shifting allocations between high-flying winners and depressed stocks, aiming to capture asymmetric returns within disruptive sectors.
